Common genetic defect highlighted for diabetes type 1 and type 2

24 March 2016

A study carried out by Maisonneuve-Rosemont Hospital in Montreal has determined a common genetic defect in beta cells that impacts both type 1 and type 2 diabetes sufferers.

Published in the journal Nature Genetics, the research showed that diabetes should no longer be referred to as a 'lifestyle disease', given the strong genetic factor that the study has identified.

Sylvie Lesage, a member of the Montreal Diabetes Research Center, stated: "Our research finds that genetics is critical for the survival of beta cells - the cells that make insulin.

"Thanks to our genetic make-up, some of us have beta cells that are tough and robust, while others have beta cells that are fragile and can't handle stress."

It is now hoped that these findings could act as a catalyst for an improved understanding of the development of diabetes in patients in the future, while also potentially leading to new avenues of treatment.

Posted by Edward Bartel

Health News is provided by Axonn Media in collaboration with Spire Healthcare. Please note that all copy above is ©Axonn Media and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.

Find a treatment, test or scan available at:


Find a consultant

Use one or more of the options below to search for a consultant and link through to view their Spire profile.


Let us help you

fill out this form and we will get back to you:

Please select a hospital

We can call you

Please enter your details below and we will call you back.

What is the aim of your enquiry?

Please select a hospital

If we are unable to reach you by phone, please include your email address so that we can get in touch...



© Spire Healthcare Group plc (2016)